Taiwan has enough of the drugs used to treat Mycoplasma pneumoniae, as it increased imports of a brand-name drug last month and expanded domestic production of generic drugs, the Food and Drug Administration (FDA) said yesterday.
As some parts of China are seeing a spike in respiratory illnesses, reportedly caused by multiple pathogens, including the M. pneumoniae bacteria, many Taiwanese media outlets have reported public concerns about children catching M. pneumoniae.
M. pneumoniae is a common bacterial respiratory tract pathogen that causes infections the whole year round in Taiwan, Centers for Disease Control (CDC) Deputy Director-General Philip Lo (羅一鈞) said on Tuesday evening, adding that it mainly spreads from person to person through respiratory droplets.
Photo: CNA
A 2011-2012 survey by the Taiwan Pediatric Infectious Diseases Alliance found that M. pneumoniae was the second-most common pathogen that caused community-acquired pneumonia in children, he said, adding that M. pneumoniae infections are most common in children aged five or older.
The epidemiology of M. pneumoniae has not changed much in 10 years, and most infections are mild, usually resolve on their own and rarely require hospitalization, Lo said.
While historical trends show that M. pneumoniae infections tend to peak every three to seven years, there has not been a significant rise in cases so far this year, he said.
One antibiotic used to treat M. pneumoniae infections in children is azithromycin powder for oral suspension, FDA Deputy Director Cheng Hwei-fang (陳惠芳) said yesterday.
The drug is used to treat bacterial infections of the respiratory tract, skin and soft tissue, as well as otitis media and sexually transmitted diseases, she said, adding that there are two valid drug permits in Taiwan.
An average of 4,680 bottles of azithromycin were used each month last year, but the average monthly usage increased to 8,050 bottles this year, so although 1.3 times more of the drug was imported, supply did not meet demand, she said,
The situation was reported in August, and a large amount of the drug was imported last month, Cheng said, adding that there are about 27,000 bottles in stock, and domestic production of a generic version of the drug has been increased by two to three times.
There are seven valid drug permits in Taiwan for azithromycin oral tablets for adults, and while the average usage is approximately 200,000 tablets per month, there are about 1.3 million tablets in stock — enough to last five to six months — and there are plans to import or manufacture about 2 million tablets next month, so there should be no shortage, she said.
FDA Medicinal Product Division head Yang Bo-wen (楊博文) said in preparation for a likely increase in infections due to Taiwan lifting its COVID-19 restrictions earlier this year and because many respiratory infectious diseases peak in autumn and winter, the FDA on Aug. 2 told drugmakers with permits for antibiotics, drugs for treating respiratory illnesses and gastrointestinal tract infections, antipyretics, and analgesics to ensure a stable supply of the products.
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to